Pulmonx Corporation Common Stock (LUNG) Stock Price

LUNGStock

$1.78+13.38%52W

Market Cap$75.18M

P/E—

PEG Ratio—

Div yield—

Beta0.27

LUNG Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)15.45%

Price vs S&P 500 (4W)-9.23%

VGM Score65.38

Book Value / Share (Quarterly)$0.91

P/TBV (Annual)3.12x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)19.03%

Cash Flow / Share (Quarterly)$-0.71

Price vs S&P 500 (YTD)-31.38%

Gross Margin (TTM)77.06%

Net Profit Margin (TTM)-55.03%

EPS (TTM)$-1.16

10-Day Avg Trading Volume0.30M

EPS Excl Extra (TTM)$-1.16

Revenue Growth (5Y)22.56%

EPS (Annual)$-1.33

ROI (Annual)-59.21%

Gross Margin (Annual)74.19%

Net Profit Margin (5Y Avg)-85.17%

Cash / Share (Quarterly)$1.30

Revenue Growth QoQ (YoY)-4.62%

ROA (Last FY)-41.77%

Revenue Growth TTM (YoY)-3.43%

EBITD / Share (TTM)$-1.09

ROE (5Y Avg)-56.08%

Operating Margin (TTM)-52.96%

Cash Flow / Share (Annual)$-0.79

P/B Ratio1.95x

P/B Ratio (Quarterly)1.40x

Net Income / Employee (Annual)$-182,400

EV / Revenue (TTM)0.66x

Net Interest Coverage (TTM)-45.91x

ROA (TTM)-38.32%

EPS Incl Extra (Annual)$-1.33

Current Ratio (Annual)5.07x

Quick Ratio (Quarterly)3.37x

3-Month Avg Trading Volume0.49M

52-Week Price Return13.38%

Revenue / Employee (TTM)$295,400

Tangible BV / Share (Quarterly)$2.16

P/S Ratio (Annual)0.84x

Asset Turnover (Annual)0.70x

52-Week High$2.89

Operating Margin (5Y Avg)-85.07%

EPS Excl Extra (Annual)$-1.33

CapEx CAGR (5Y)-13.06%

26-Week Price Return25.35%

Quick Ratio (Annual)4.15x

13-Week Price Return27.14%

Total Debt / Equity (Annual)0.69x

Current Ratio (Quarterly)4.32x

Enterprise Value$58.14M

Revenue / Share Growth (5Y)19.39%

Asset Turnover (TTM)0.70x

Book Value / Share Growth (5Y)-27.16%

Revenue / Employee (Annual)$305,700

Inventory Turnover (Annual)1.43x

Pretax Margin (Annual)-58.98%

Cash / Share (Annual)$1.67

3-Month Return Std Dev104.83%

Gross Margin (5Y Avg)74.00%

Net Income / Employee (TTM)$-162,600

ROE (Last FY)-99.79%

Net Interest Coverage (Annual)-20.81x

EPS Basic Excl Extra (Annual)$-1.33

Receivables Turnover (TTM)6.21x

Total Debt / Equity (Quarterly)0.96x

EPS Incl Extra (TTM)$-1.16

Receivables Turnover (Annual)7.18x

ROI (TTM)-55.28%

P/S Ratio (TTM)0.87x

Pretax Margin (5Y Avg)-84.48%

Revenue / Share (Annual)$2.22

Tangible BV / Share (Annual)$2.16

Price vs S&P 500 (52W)-2.16%

Year-to-Date Return-19.46%

5-Day Price Return-1.11%

EPS Normalized (Annual)$-1.33

ROA (5Y Avg)-32.35%

Net Profit Margin (Annual)-59.67%

Month-to-Date Return-6.81%

Cash Flow / Share (TTM)$-1.58

EBITD / Share (Annual)$-1.29

Operating Margin (Annual)-59.30%

LT Debt / Equity (Annual)0.68x

ROI (5Y Avg)-40.34%

LT Debt / Equity (Quarterly)0.95x

EPS Basic Excl Extra (TTM)$-1.16

P/TBV (Quarterly)3.12x

P/B Ratio (Annual)1.68x

Inventory Turnover (TTM)1.23x

Pretax Margin (TTM)-54.34%

Book Value / Share (Annual)$1.30

Price vs S&P 500 (13W)24.46%

Beta0.27x

Revenue / Share (TTM)$2.06

ROE (TTM)-96.66%

52-Week Low$1.13

vGradeB

gGradeD

mGradeB

vgmGradeB

LUNG Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Jul 29, 2026	-$0.28	-$0.24	+14.29%(+$0.04)
Q1 2026	Apr 29, 2026	-$0.33	-$0.33	-1.02%(-$0.00)
Q4 2025	Mar 4, 2026	-$0.39	-$0.25	+35.06%(+$0.14)
Q3 2025	Nov 12, 2025	-$0.42	-$0.34	+18.72%(+$0.08)
Q2 2025	Jul 30, 2025	-$0.40	-$0.38	+5.39%(+$0.02)

LUNG Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.00

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
LUNGPulmonx Corporation Common Stock	B	D	B	0.9x	22.6%	77.1%	-53.0%	$1.78
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Pulmonx Corporation Common Stock

Pulmonx develops minimally invasive treatments for severe emphysema and COPD, with its flagship Zephyr Endobronchial Valve supported by diagnostic assessment platforms. The company sells its medical devices to hospitals and distributors across the U.S., Europe, Middle East, Africa, and Asia Pacific. Pulmonx serves patients with limited treatment options in a significant respiratory disease market.

LUNG Next Earnings Report

Report dateOct 27, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.26

Revenue estimate$21.94M

Also reporting on Oct 27, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for October 2026

LUNG Insider Transactions

SellSep 1, 2026
FRENCH GLENDON E III
Chief Executive Officer
Shares: 41,882Value: $94,653
SellSep 1, 2026
LEHMAN DAVID AARON
General Counsel
Shares: 14,334Value: $32,395
SellSep 1, 2026
RADHAKRISHNAN SRIKANTH
Chief Technology Officer
Shares: 14,245Value: $32,194
SellSep 1, 2026
ROSE GEOFFREY BERAN
Officer
Shares: 7,879Value: $17,807

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for September 2026

Companies in Related Industries

CNXUConexeu Sciences Inc. Common StockOrthopedic & Prosthetic Devices
STEXStreamex Corp. Common StockElectromedical Equipment
HYPRHyperfine, Inc. Class A Common StockElectromedical Equipment
NTRBNutriband Inc. Common StockOrthopedic & Prosthetic Devices
OMOutset Medical, Inc. Common StockElectromedical Equipment
ECORelectroCore, Inc. Common StockElectromedical Equipment
OPXSOptex Systems Holdings, INCOptical Instruments & Lenses
SPAISafe Pro Group Inc. Common StockOrthopedic & Prosthetic Devices

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.0

Buy

Consensus rating

52-Week Range

Low$1.13

High$2.89